| Date Filed | Type | Description |
| 08/25/2023 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 02/23/2023 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/05/2022 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Granted 925,069 options to buy
@ $13.18, valued at
$12.2M
|
|
| 11/21/2022 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 56,125 options to buy
@ $2.7, valued at
$151.5k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2022 |
SC 13G/A
| Hansen Carl L. G. reports a 19.5% stake in AbCellera Biologics Inc. |
| 12/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Hansen Carl L. G. (CEO) has filed a Form 4 on AbCellera Biologics Inc.|
Txns:
| Exercised 224,500 shares
@ $15.03, valued at
$3.4M
Exercised 224,500 options to buy
@ $2.7, valued at
$606.2k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
3
| Hansen Carl L. G. (CEO) has filed a Form 3 on AbCellera Biologics Inc. |